Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 4/20 | 0.40 |
| ▸ | CAPN1 | P07384 | 3/20 | 0.39 |
| ▸ | CCR1 | P32246 | 2/20 | 0.39 |
| ▸ | CTSL | P07711 | 1/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.38 |
| ▸ | CTSK | P43235 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7668502 | 0.91 | CMA1 (0.40) | — | |
| SCHEMBL7665843 | 0.86 | CTSD (0.41) | CTSDCAPN1CCR1CTSLCTSB | |
| SCHEMBL7670720 | 0.86 | PRSS8 (0.47) | ELANECYP3A4 | |
| SCHEMBL7661712 | 0.86 | CTSD (0.40) | CTSDCAPN1CCR1CTSLCTSB | |
| SCHEMBL7668441 | 0.85 | CAPN1 (0.44) | CTSDCAPN1CCR1CTSLCTSB | |
| SCHEMBL7669892 | 0.84 | CCR1 (0.47) | CTSDCAPN1CCR1CTSLCTSB | |
| SCHEMBL7660620 | 0.83 | CTSD (0.45) | CTSDCAPN1CCR1CTSLCTSB | |
| SCHEMBL7661037 | 0.83 | CTSD (0.41) | CTSDCAPN1CCR1CTSLCTSB | |
| SCHEMBL7661080 | 0.79 | CCR1 (0.46) | CTSDCAPN1CCR1CTSLCTSB | |
| SCHEMBL7670856 | 0.78 | CCR1 (0.52) | CTSDCAPN1CCR1CTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6410576-B1 | ANTIINFLAMMATORY AGENTS; CARDIOVASCULAR DISORDERS | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2002-06-25 | — | — | US | disclosed |